Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery–associated acute kidney injury: A multicenter randomized controlled trial

Journal of Critical Care

Volumn 38, Issue , 2017, Pages 253-258

  Mitaka, Chieko ^a,b   Ohnuma, Tetsu ^c   Murayama, Takanori ^c   Kunimoto, Fumio ^d   Nagashima, Michio ^e   Takei, Tetsuhiro ^e   Iguchi, Naoya ^f   Tomita, Makoto ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d GUNMA UNIVERSITY HOSPITAL   (Japan)

^e YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

^f OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute kidney injury; Atrial natriuretic peptide; Cardiac surgery; Medical costs; Renal function

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; CREATININE; PLACEBO; ATRIAL NATRIURETIC FACTOR;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CARDIAC SURGERY INTENSIVE CARE UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFECT; FEMALE; FOLLOW UP; HEART SURGERY; HOSPITALIZATION; HUMAN; JAPAN; JAPANESE (CITIZEN); KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; URINE VOLUME; ACUTE KIDNEY INJURY; CLINICAL TRIAL; HEALTH CARE COST; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION TEST; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; UTILIZATION;

ACUTE KIDNEY INJURY; AGED; ATRIAL NATRIURETIC FACTOR; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; FEMALE; HEALTH CARE COSTS; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; JAPAN; KIDNEY FUNCTION TESTS; LENGTH OF STAY; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY;

EID: 85013627384     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2016.12.004     Document Type: Article

References (30)

1. [1] Karkouti, K., Wijeysundera, D.N., Yau, T.M., Callum, J.L., Cheng, D.C., Crowther, M., et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 119 (2009), 495–502.
2. [2] Rosner, M.H., Okusa, M.D., Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1 (2006), 19–32.
3. [3] Bellomo, R., Auriemma, S., Fabbri, A., D'Onofrio, A., Katz, N., McCullough, P.A., et al. The pathophysiology of cardiac surgery–associated acute kidney injury (CSA-AKI). Int J Artif Organs 31 (2008), 166–178.
4. [4] Mao, H., Katz, N., Ariyanon, W., Blanca-Martos, L., Adýbelli, Z., Giuliani, A., et al. Cardiac surgery–associated acute kidney injury. Blood Purif 37:Suppl. 2 (2014), 34–50.
5. [5] Thiele, R.H., Isbell, J.M., Rosner, M.H., AKI associated with cardiac surgery. Clin J Am Soc Nephrol 10 (2015), 500–514.
6. [6] Dasta, J.F., Kane-Gill, S.L., Durtschi, A.J., Pathak, D.S., Kellum, J.A., Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 23 (2008), 1970–1974.
7. [7] Levin, E.R., Gardner, D.G., Samson, W.K., Natriuretic peptide. N Engl J Med 339 (1998), 321–328.
8. [8] Marin-Grez, M., Fleming, J.T., Steinhausen, M., Atrial natriuretic peptide causes pre-glomerular vasodilation and post-glomerular vasoconstriction in rat kidney. Nature 324 (1985), 473–476.
9. [9] Kiberd, B.A., Larson, T.S., Robertson, C.R., Jamison, R.L., Effect of atrial natriuretic peptide on vasa recta blood flow in the rat. Am J Physiol 252 (1987), F1112–F1117 [Renal Fluid Electrolyte Physiol.21].
10. [10] Shaw, S.G., Weidmann, P., Hodler, J., Zimmermann, A., Patemostro, A., Atrial natriuretic peptide protects against ischemic renal failure in the rat. J Clin Invest 80 (1987), 1232–1237.
11. [11] Kiemer, A.K., Hartung, T., Vollmar, A.M., cGMP-mediated inhibition of TNF-α production by the atrial natriuretic peptide in murine macrophages. J Immunol 165 (2000), 175–181.
12. [12] Kiemer, A.K., Weber, N.C., Fürst, R., Bildner, N., Kulhanek-Heinze, S., Vollmar, A.M., Inhibition of p38 MARK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-α–induced actin polymerization and endothelial permeability. Circ Res 90 (2002), 874–881.
13. [13] Ladetzki-Baehs, K., Keller, M., Kiemer, A.K., Koch, E., Zahler, S., Wendel, A., et al. Atrial natriuretic peptide, a regulator of nuclear factor-κB activation in vivo. Endocrinology 148 (2007), 332–336.
14. [14] Tulaf, M., Mitaka, C., Hnin Si, M.K., Abe, S., Kitagawa, M., Ikeda, S., et al. Atrial natriuretic peptide attenuates kidney-lung crosstalk in kidney injury. J Surg Res 186 (2014), 217–225.
15. [15] Mitaka, C., Hnin Si, M.K., Tulaf, M., Yu, Q., Uchida, T., Abe, S., et al. Effects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury. Intensive Care Med Exp, 2, 2014, 28.
16. [16] Ambwani, J., Ubhrani, D., Saad, R., Dunning, J., Could atrial natriuretic peptide be a useful drug therapy for high-risk patients after cardiac surgery?. Interact Cardiovasc Thorac Surg 8 (2009), 474–478.
17. [17] Mitaka, C., Kudo, T., Haraguchi, G., Tomita, M., Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis. Crit Care, 15, 2011, R258.
18. [18] Sezai, A., Hata, M., Niino, T., Yoshitake, I., Unosawa, S., Wakui, S., et al. Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose Human ANP Infusion Therapy during cardiac surgery) for left ventricular dysfunction. J Am Coll Cardiol 55 (2010), 1844–1851.
19. [19] Sezai, A., Hata, M., Niino, T., Yoshitake, I., Unosawa, S., Wakui, S., et al. Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose hANP Infusion Therapy during cardiac surgery) trial for CKD. J Am Coll Cardiol 58 (2011), 897–903.
20. [20] Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl, 2, 2012, 1–138.
21. [21] RENAL Replacement Therapy Study Investigators, Bellomo, R., Cass, A., Cole, L., Finfer, S., Gallagher, M., et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361 (2009), 1627–1638.
22. [22] Abuelo, J.G., Normotensive ischemic acute renal failure. N Engl J Med 357 (2007), 797–805.
23. [23] Swärd, K., Valsson, F., Odencrants, P., Samuelsson, O., Ricksten, S.E., Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 32 (2004), 1310–1315.
24. [24] Waikar, S.S., Bonventre, J.V., Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20 (2009), 672–679.
25. [25] Shlipak, M.G., Coca, S.G., Wang, Z., Devarajan, P., Koyner, J.L., Patel, U.D., et al. TRIBE-AKI Consortium. Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. Am J Kidney Dis 58 (2011), 366–373.
26. [26] Hayashi, Y., Ohtani, M., Hiraishi, T., Kobayashi, Y., Nakamura, T., Synthetic human α-atrial natriuretic peptide infusion in management after open heart operation. ASAIO J 49 (2003), 320–324.
27. [27] Lassnigg, A., Donner, E., Grubhofer, G., Presterl, E., Druml, W., Hiesmayr, M., Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11 (2000), 97–104.
28. [28] Ho, K.M., Sheridan, D., Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ, 333, 2006.
29. [29] Demirjian, S., Schold, J.D., Navia, J., Mastracci, T.M., Paganini, E.P., Yared, J.P., et al. Predictive models for acute kidney injury following cardiac surgery. Am J Kidney Dis 59 (2012), 382–389.
30. [30] Thakar, C.V., Arrigain, S., Worley, S., Yared, J.P., Paganini, E.P.A., A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16 (2005), 162–168.